Innovating Works

FORMBECC

Financiado
LaminarPace System a breakthrough technology for dry formulation of sensitive p...
LaminarPace System a breakthrough technology for dry formulation of sensitive pharmaceuticals at room temperature enhancing their stability beyond the cold chain Formulation of sensitive drugs in a stable manner poses problems with currently applied technologies: the substances need to be either heated up to +80 °C or frozen to -80 °C. Many valuable biological pharmaceuticals need to be ke... Formulation of sensitive drugs in a stable manner poses problems with currently applied technologies: the substances need to be either heated up to +80 °C or frozen to -80 °C. Many valuable biological pharmaceuticals need to be kept and transported in a liquid phase at fixed temperatures, which renders them impractical and costly. The global healthcare community, with the World Health Organisation in the lead, is looking for options to step out of the cold chain and provide more accessible medication to all communities. In the LaminarPace project, Ziccum AB is developing a gentle, room temperature spray-drying technology for the application in the pharmaceutical industry. The system is operational on a laboratory scale and pilot-tested now. It could successfully lead to the development of new biologics: vaccines, drugs and therapies. An industrial-scale system based on the same principles of operation will be developed and commercialised. The objective is to set the large system into BioTech production lines. LaminarPace process is fully controllable according to Good Manufacturing Practice and produces carefully-engineered, stable and easily-absorbed formulations. ver más
31/01/2019
71K€
Duración del proyecto: 6 meses Fecha Inicio: 2018-07-13
Fecha Fin: 2019-01-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2019-01-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 71K€
Líder del proyecto
ZICCUM AB No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5